VNI: N-[(1R)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide
VNI is a Ligand Of Interest in 3GW9 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3GW9_VNI_D_490 | 68% | 39% | 0.122 | 0.933 | 1.13 | 1.34 | 1 | 4 | 1 | 0 | 100% | 1 |
| 3GW9_VNI_C_490 | 67% | 23% | 0.138 | 0.948 | 1.27 | 2.08 | 4 | 13 | 0 | 0 | 100% | 1 |
| 3GW9_VNI_B_490 | 64% | 28% | 0.134 | 0.934 | 1.15 | 1.85 | 3 | 8 | 2 | 0 | 100% | 1 |
| 3GW9_VNI_A_490 | 59% | 31% | 0.15 | 0.933 | 1.21 | 1.64 | 2 | 5 | 1 | 0 | 100% | 1 |
| 4UYL_VNI_B_590 | 30% | 24% | 0.262 | 0.929 | 1.9 | 1.37 | 4 | 5 | 11 | 0 | 100% | 1 |
